Komura K - Search Results

1

Can bladder preservation therapy come to the center stage?

Inamoto T, Ibuki N, Komura K, Juri H, Yamamoto K, Yamamoto K, Fujita K, Nonomura N, Narumi Y, Azuma H. Inamoto T, et al. Among authors: komura k. Int J Urol. 2018 Feb;25(2):134-140. doi: 10.1111/iju.13495. Epub 2017 Nov 23. Int J Urol. 2018. PMID: 29171098 Review.

2

[Renal cell carcinoma in a horseshoe kidney: a case report].

Ibuki N, Uehara H, Komura K, Koyama K, Inamoto T, Segawa N, Tuji M, Azuma H, Katsuoka Y. Ibuki N, et al. Among authors: komura k. Hinyokika Kiyo. 2009 Oct;55(10):611-3. Hinyokika Kiyo. 2009. PMID: 19926945 Free article. Review. Japanese.

3

[A pheochromocytoma of urinary bladder treated with neoadjuvant chemotherapy].

Ibuki N, Komura K, Koyama K, Inamoto T, Segawa N, Tanimoto K, Tuji M, Azuma H, Katsuoka Y. Ibuki N, et al. Among authors: komura k. Hinyokika Kiyo. 2009 Dec;55(12):765-8. Hinyokika Kiyo. 2009. PMID: 20048562 Free article. Japanese.

4

Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma.

Komura K, Inamoto T, Tsuji M, Ibuki N, Koyama K, Ubai T, Azuma H, Katsuoka Y. Komura K, et al. Int J Clin Oncol. 2010 Dec;15(6):594-600. doi: 10.1007/s10147-010-0082-5. Epub 2010 Apr 27. Int J Clin Oncol. 2010. PMID: 20422244

5

Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.

Azuma H, Inamoto T, Ibuki N, Ubai T, Kotake Y, Takahara K, Kiyama S, Nomi H, Uehara H, Komura K, Yamamoto K, Narumi Y, Katsuoka Y. Azuma H, et al. Among authors: komura k. Int J Oncol. 2010 Oct;37(4):773-85. doi: 10.3892/ijo_00000727. Int J Oncol. 2010. PMID: 20811698

6

Combination therapy with VP16 and ethinylestradiol for hormone-refractory prostate cancer: good response with tolerability.

Azuma H, Inamoto T, Takahara K, Ibuki N, Koyama K, Utimoto S, Fujisue Y, Uehara H, Komura K, Nomi H, Ubai T, Katsuoka Y. Azuma H, et al. Among authors: komura k. Anticancer Res. 2010 Sep;30(9):3737-45. Anticancer Res. 2010. PMID: 20944163 Clinical Trial.

7

Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.

Azuma H, Inamoto T, Ibuki N, Ubai T, Kotake Y, Takahara K, Kiyama S, Nomi H, Uehara H, Komura K, Yamamoto K, Narumi Y, Katsuoka Y. Azuma H, et al. Among authors: komura k. Int J Oncol. 2011 Jan;38(1):13-24. Int J Oncol. 2011. PMID: 21109921

8

Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer.

Fujisue Y, Azuma H, Inamoto T, Komura K, Agarwal PK, Masuda H, Watsuji T, Katsuoaka Y. Fujisue Y, et al. Among authors: komura k. World J Urol. 2011 Oct;29(5):689-94. doi: 10.1007/s00345-010-0628-1. Epub 2010 Dec 16. World J Urol. 2011. PMID: 21161537

9

Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer.

Inamoto T, Komura K, Watsuji T, Azuma H. Inamoto T, et al. Among authors: komura k. Clin Med Insights Oncol. 2011;5:101-6. doi: 10.4137/CMO.S7073. Epub 2011 Apr 19. Clin Med Insights Oncol. 2011. PMID: 21603245 Free PMC article.

10

Specific body mass index cut-off value in relation to survival of patients with upper urinary tract urothelial carcinomas.

Inamoto T, Komura K, Watsuji T, Azuma H. Inamoto T, et al. Among authors: komura k. Int J Clin Oncol. 2012 Jun;17(3):256-62. doi: 10.1007/s10147-011-0284-5. Epub 2011 Jul 8. Int J Clin Oncol. 2012. PMID: 21739125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters